Coronavirus: Funding for vaccine development | Fieldfisher
Skip to main content

Coronavirus: Funding for vaccine development



United Kingdom, United States

Bringing you the latest developments on the Life Sciences & COVID-19
We are all navigating unchartered waters as business and society faces up to the impact of COVID-19.  We very much hope you and your loved ones remain in good health. 

 Please be assured that Fieldfisher is continuing to work with clients to navigate COVID-19 related issues and on business as usual needs.  Do get in touch with us if you would like to chat anything through.

Public Health England (PHE) scientists are playing a critical role in international efforts to find the vaccine, having been awarded $500,000 by the US Food and Drug Administration (FDA) to bolster the international response. The funding comes as the Coalition for Epidemic Preparedness Innovations (CEPI) funds PHE to evaluate vaccines in their pipeline vaccine that are destined for clinical trials as early as April 2020. The UK government has previously announced £20million of funding for vaccine development, awarded to CEPI, who will award significant further funding to support PHE’s work.
Professor Miles Carroll, deputy director, National Infection Service, Public Health England, said: “Public Health England is uniquely positioned to support and drive the country’s hunt for a coronavirus vaccine – using tried and tested methods for the rapid development of interventions for emerging diseases.

Sign up to our email digest

Click to subscribe or manage your email preferences.